These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8858114)

  • 1. Defective degradation of leukotrienes in peroxisomal-deficient human hepatocytes.
    Mayatepek E; Tiepelmann B
    Biochem Biophys Res Commun; 1996 Oct; 227(1):131-4. PubMed ID: 8858114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.
    Mayatepek E; Lehmann WD; Fauler J; Tsikas D; Frölich JC; Schutgens RB; Wanders RJ; Keppler D
    J Clin Invest; 1993 Mar; 91(3):881-8. PubMed ID: 8450067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisomal degradation of leukotrienes by beta-oxidation from the omega-end.
    Jedlitschky G; Huber M; Völkl A; Müller M; Leier I; Müller J; Lehmann WD; Fahimi HD; Keppler D
    J Biol Chem; 1991 Dec; 266(36):24763-72. PubMed ID: 1761571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisomal leukotriene degradation: biochemical and clinical implications.
    Jedlitschky G; Mayatepek E; Keppler D
    Adv Enzyme Regul; 1993; 33():181-94. PubMed ID: 8356907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cysteinyl leukotrienes and their metabolites in bile of patients with peroxisomal or mitochondrial beta-oxidation defects.
    Mayatepek E; Ferdinandusse S; Meissner T; Wanders RJ
    Clin Chim Acta; 2004 Jul; 345(1-2):89-92. PubMed ID: 15193981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of leukotrienes.
    Ferdinandusse S; Meissner T; Wanders RJ; Mayatepek E
    Biochem Biophys Res Commun; 2002 Apr; 293(1):269-73. PubMed ID: 12054595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic inactivation of leukotrienes.
    Keppler D; Huber M; Baumert T; Guhlmann A
    Adv Enzyme Regul; 1989; 28():307-19. PubMed ID: 2624175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urinary excretion of LTB4 and omega-carboxy-LTB4 in patients with Zellweger syndrome.
    Mayatepek E; Flock B
    Clin Chim Acta; 1999 Apr; 282(1-2):151-5. PubMed ID: 10340443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of cysteinyl leukotrienes in monkey and man.
    Huber M; Müller J; Leier I; Jedlitschky G; Ball HA; Moore KP; Taylor GW; Williams R; Keppler D
    Eur J Biochem; 1990 Nov; 194(1):309-15. PubMed ID: 2174780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic transformations of leukotriene B4 in primary cultures of human hepatocytes.
    Wheelan P; Hankin JA; Bilir B; Guenette D; Murphy RC
    J Pharmacol Exp Ther; 1999 Jan; 288(1):326-34. PubMed ID: 9862787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans.
    Diczfalusy U; Kase BF; Alexson SE; Björkhem I
    J Clin Invest; 1991 Sep; 88(3):978-84. PubMed ID: 1885782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene uptake by hepatocytes and hepatoma cells.
    Leier I; Müller M; Jedlitschky G; Keppler D
    Eur J Biochem; 1992 Oct; 209(1):281-9. PubMed ID: 1327771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol-induced inhibition of leukotriene degradation by omega-oxidation.
    Baumert T; Huber M; Mayer D; Keppler D
    Eur J Biochem; 1989 Jun; 182(2):223-9. PubMed ID: 2544422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisomal L-pipecolic acid oxidation is deficient in liver from Zellweger syndrome patients.
    Mihalik SJ; Moser HW; Watkins PA; Danks DM; Poulos A; Rhead WJ
    Pediatr Res; 1989 May; 25(5):548-52. PubMed ID: 2717271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of leukotriene omega-oxidation by omega-trifluoro analogs of leukotrienes.
    Jedlitschky G; Leier I; Huber M; Mayer D; Keppler D
    Arch Biochem Biophys; 1990 Nov; 282(2):333-9. PubMed ID: 2173482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of ethanol and acetaldehyde on the metabolism of prostaglandin E2 and leukotriene B4 in isolated rat hepatocytes.
    Hankin JA; Clay CE; Murphy RC
    J Pharmacol Exp Ther; 1998 Apr; 285(1):155-61. PubMed ID: 9536005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytanoyl-CoA hydroxylase is present in human liver, located in peroxisomes, and deficient in Zellweger syndrome: direct, unequivocal evidence for the new, revised pathway of phytanic acid alpha-oxidation in humans.
    Jansen GA; Mihalik SJ; Watkins PA; Moser HW; Jakobs C; Denis S; Wanders RJ
    Biochem Biophys Res Commun; 1996 Dec; 229(1):205-10. PubMed ID: 8954107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Halothane metabolism. Impairment of hepatic omega-oxidation of leukotrienes in vivo and in vitro.
    Huwyler J; Jedlitschky G; Keppler D; Gut J
    Eur J Biochem; 1992 Jun; 206(3):869-79. PubMed ID: 1318837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of beta-oxidation products of sulfidopeptide leukotrienes.
    Stene DO; Murphy RC
    J Biol Chem; 1988 Feb; 263(6):2773-8. PubMed ID: 2830262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
    Van Veldhoven PP
    Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.